logo
logo

Revolutionizing Medical Ai Development: Flywheel Announces $54 Million In Series D Funding Led By Novalis Lifesciences And Nventures

Jun 27, 2023•about 2 years ago

Amount Raised

$54 Million

MinneapolisInformation Technology

Investors

NvidiaFaegre Drinker Biddle & Reath LlpGreat North VenturesSeraphGundersen Health SystemI SelectIntuitive VenturesHewlett Packard EnterpriseBeringea8 VcInvenshureMicrosoftN VenturesNovalis Life Sciences Llc

Description

Flywheel, the leading medical imaging data and AI platform, announces it has raised $54 million in Series D funding with more to come soon. This latest round of funding was co-led by Novalis LifeSciences LLC and NVentures, NVIDIA’s venture capital arm. Microsoft also participated in the round, along with insiders Invenshure, 8VC, Beringea, Hewlett Packard Enterprise, Intuitive Ventures, iSelect, Gundersen Health System, Seraph, and Great North Ventures. Faegre Drinker Biddle & Reath LLP served as counsel to Flywheel in connection with the financing.

Company Information

Company

Flywheel

Location

1015 GLENWOOD AVENUE

Minneapolis, Minnesota, United States

About

Flywheel is the pioneering medical imaging data and AI platform powering healthcare innovation through streamlined data aggregation, curation and management. By leveraging cloud scalability and automating workflows, Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payors, system integrators, AI developers and academic medical centers.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech